COM:CENTURYTX

Century Therapeutics

Stock

Last Close

1.24

22/11 21:00

Market Cap

102.89M

Beta: -

Volume Today

511.90K

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-244.77M -	-53.58M 78.11%	-95.82M 78.86%	-130.93M 36.64%	-136.67M 4.38%
depreciation and amortization	249K -	1.40M 463.05%	3.75M 167.33%	8.44M 125.19%	13.04M 54.55%
deferred income tax		4.72M -			2.36M -
stock based compensation	147K -	876K 495.92%	4.66M 432.19%	10.67M 128.85%	14.62M 37.05%
change in working capital	2.26M -	4.86M 115.23%	-2.80M 157.53%	123.94M 4,531.36%	9.16M 92.61%
accounts receivables
inventory
accounts payables	1.23M -	2.06M 67.23%	-1.85M 189.62%	-4.79M 159.09%	-2.36M 50.69%
other working capital	1.03M -	2.80M 172.90%	-949K 133.89%	128.73M 13,665.12%	11.52M 91.05%
other non cash items	225.95M -	444K 99.80%	1.21M 172.30%	1.93M 59.64%	8.92M 362.07%
net cash provided by operating activities	-16.17M -	-41.27M 155.25%	-89.00M 115.66%	14.05M 115.79%	-88.57M 730.29%
investments in property plant and equipment	-2.46M -	-9.82M 299.39%	-44.97M 357.71%	-30.60M 31.95%	-13.74M 55.12%
acquisitions net	24.17M -	-4.72M 119.54%	-30.34M 542.44%	-238.22M 685.27%	-269.81M 13.26%
purchases of investments	-41.54M -	-49.86M 20.03%	-330.03M 561.92%	-254M 23.04%	-209.03M 17.70%
sales maturities of investments	-24.17M -	41.65M 272.35%	76.67M 84.07%	271.48M 254.10%	283.90M 4.58%
other investing activites	24.17M -		30.34M -	238.22M 685.27%	269.81M 13.26%
net cash used for investing activites	-19.83M -	-22.76M 14.74%	-298.34M 1,210.97%	-13.13M 95.60%	61.13M 565.66%
debt repayment					-10.24M -
common stock issued	74.84M -	38.10M 49.09%	221.62M 481.67%	27.16M 87.75%	516K 98.10%
common stock repurchased
dividends paid
other financing activites	74.84M -	9.59M 87.19%	196.16M 1,945.45%
net cash used provided by financing activities	74.84M -	47.69M 36.28%	417.77M 776.02%	27.16M 93.50%	-9.72M 135.81%
effect of forex changes on cash					220K -
net change in cash	38.84M -	-16.34M 142.06%	30.43M 286.30%	28.08M 7.73%	-36.94M 231.55%
cash at beginning of period	31.42M -	44.06M 40.22%	27.73M 37.07%	58.16M 109.76%	84.27M 44.88%
cash at end of period	70.26M -	27.73M 60.54%	58.16M 109.76%	86.24M 48.28%	47.32M 45.13%
operating cash flow	-16.17M -	-41.27M 155.25%	-89.00M 115.66%	14.05M 115.79%	-88.57M 730.29%
capital expenditure	-2.46M -	-9.82M 299.39%	-44.97M 357.71%	-30.60M 31.95%	-13.74M 55.12%
free cash flow	-18.63M -	-51.09M 174.29%	-133.97M 162.21%	-16.55M 87.65%	-102.30M 518.08%

All numbers in (except ratios and percentages)